

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ethanol oxidation (GO:0006069) | 6.46008249 |
| 2 | dopaminergic neuron differentiation (GO:0071542) | 6.18424985 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 5.67482297 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.67482297 |
| 5 | biotin metabolic process (GO:0006768) | 5.65559676 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 5.64081292 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 5.36558751 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.36558751 |
| 9 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 5.30953816 |
| 10 | axonemal dynein complex assembly (GO:0070286) | 5.28721952 |
| 11 | urea metabolic process (GO:0019627) | 5.24390599 |
| 12 | urea cycle (GO:0000050) | 5.24390599 |
| 13 | branching involved in prostate gland morphogenesis (GO:0060442) | 5.22896924 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 5.21969895 |
| 15 | ethanol metabolic process (GO:0006067) | 4.98232361 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.92980876 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.92011834 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.92011834 |
| 19 | tryptophan catabolic process (GO:0006569) | 4.92011834 |
| 20 | nitrogen cycle metabolic process (GO:0071941) | 4.87708598 |
| 21 | ear development (GO:0043583) | 4.84191920 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 4.79106905 |
| 23 | negative regulation of sterol transport (GO:0032372) | 4.79106905 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.75250357 |
| 25 | cysteine metabolic process (GO:0006534) | 4.73658974 |
| 26 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 4.72270434 |
| 27 | alkaloid metabolic process (GO:0009820) | 4.69034863 |
| 28 | bile acid and bile salt transport (GO:0015721) | 4.62622734 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.59696145 |
| 30 | tryptophan metabolic process (GO:0006568) | 4.56091316 |
| 31 | iron ion import (GO:0097286) | 4.53355029 |
| 32 | bile acid biosynthetic process (GO:0006699) | 4.52133225 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.51068160 |
| 34 | glyoxylate metabolic process (GO:0046487) | 4.50641625 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.49138043 |
| 36 | alpha-linolenic acid metabolic process (GO:0036109) | 4.46274565 |
| 37 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.39887364 |
| 38 | * regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 4.28877889 |
| 39 | homocysteine metabolic process (GO:0050667) | 4.24328014 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.23990918 |
| 41 | Golgi transport vesicle coating (GO:0048200) | 4.23004390 |
| 42 | COPI coating of Golgi vesicle (GO:0048205) | 4.23004390 |
| 43 | desmosome organization (GO:0002934) | 4.20367750 |
| 44 | bile acid metabolic process (GO:0008206) | 4.17293419 |
| 45 | regulation of fibrinolysis (GO:0051917) | 4.15972515 |
| 46 | complement activation, alternative pathway (GO:0006957) | 4.10969917 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.10630492 |
| 48 | * epithelial cell maturation (GO:0002070) | 4.07306463 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.06693144 |
| 50 | protein carboxylation (GO:0018214) | 4.06693144 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.00930612 |
| 52 | regulation of cell proliferation involved in kidney development (GO:1901722) | 4.00592986 |
| 53 | coenzyme catabolic process (GO:0009109) | 3.99338912 |
| 54 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.98381198 |
| 55 | regulation of complement activation (GO:0030449) | 3.97670679 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 3.96323519 |
| 57 | vitamin transmembrane transport (GO:0035461) | 3.96270218 |
| 58 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.93611786 |
| 59 | reverse cholesterol transport (GO:0043691) | 3.92477066 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.92409880 |
| 61 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.88235198 |
| 62 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.86496077 |
| 63 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.86314502 |
| 64 | apical protein localization (GO:0045176) | 3.85763370 |
| 65 | embryonic camera-type eye morphogenesis (GO:0048596) | 3.84187162 |
| 66 | maternal placenta development (GO:0001893) | 3.83840363 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79747239 |
| 68 | motile cilium assembly (GO:0044458) | 3.78058695 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.76350634 |
| 70 | regulation of water loss via skin (GO:0033561) | 3.75361099 |
| 71 | triglyceride homeostasis (GO:0070328) | 3.73680570 |
| 72 | acylglycerol homeostasis (GO:0055090) | 3.73680570 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.73423005 |
| 74 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.71981124 |
| 75 | arginine metabolic process (GO:0006525) | 3.67275917 |
| 76 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66250971 |
| 77 | protein-lipid complex remodeling (GO:0034368) | 3.66250971 |
| 78 | macromolecular complex remodeling (GO:0034367) | 3.66250971 |
| 79 | glycine metabolic process (GO:0006544) | 3.64285579 |
| 80 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.62540528 |
| 81 | flavonoid metabolic process (GO:0009812) | 3.61003339 |
| 82 | endothelial cell chemotaxis (GO:0035767) | 3.60759549 |
| 83 | nucleobase catabolic process (GO:0046113) | 3.59800704 |
| 84 | cilium movement (GO:0003341) | 3.59770616 |
| 85 | cellular glucuronidation (GO:0052695) | 3.59540583 |
| 86 | primary alcohol catabolic process (GO:0034310) | 3.58045304 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 3.57963393 |
| 88 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.53892088 |
| 89 | embryonic eye morphogenesis (GO:0048048) | 3.52749882 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.51304573 |
| 91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.50727497 |
| 92 | regulation of cholesterol esterification (GO:0010872) | 3.49250762 |
| 93 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.48872218 |
| 94 | midgut development (GO:0007494) | 3.48694186 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.48406650 |
| 96 | cholesterol efflux (GO:0033344) | 3.48197639 |
| 97 | cellular modified amino acid catabolic process (GO:0042219) | 3.47754597 |
| 98 | drug catabolic process (GO:0042737) | 3.45214523 |
| 99 | amino-acid betaine metabolic process (GO:0006577) | 3.45050981 |
| 100 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.44534534 |
| 101 | lysine catabolic process (GO:0006554) | 3.42204366 |
| 102 | lysine metabolic process (GO:0006553) | 3.42204366 |
| 103 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.40867326 |
| 104 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.40506254 |
| 105 | uterus development (GO:0060065) | 3.40126029 |
| 106 | multicellular organismal water homeostasis (GO:0050891) | 3.39865317 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.38117533 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.38117533 |
| 109 | mammary gland epithelial cell differentiation (GO:0060644) | 3.36726419 |
| 110 | serine family amino acid metabolic process (GO:0009069) | 3.36695102 |
| 111 | proline biosynthetic process (GO:0006561) | 3.35700065 |
| 112 | response to nitrosative stress (GO:0051409) | 3.35563056 |
| 113 | aldehyde catabolic process (GO:0046185) | 3.34186178 |
| 114 | lung lobe morphogenesis (GO:0060463) | 3.33487576 |
| 115 | ketone body metabolic process (GO:1902224) | 3.33467995 |
| 116 | dopamine biosynthetic process (GO:0042416) | 3.31262972 |
| 117 | S-adenosylmethionine metabolic process (GO:0046500) | 3.31045991 |
| 118 | asymmetric protein localization (GO:0008105) | 3.30631960 |
| 119 | imidazole-containing compound metabolic process (GO:0052803) | 3.29216898 |
| 120 | establishment of apical/basal cell polarity (GO:0035089) | 3.29211671 |
| 121 | exocrine pancreas development (GO:0031017) | 3.27444988 |
| 122 | intestinal epithelial cell development (GO:0060576) | 3.23182957 |
| 123 | amine catabolic process (GO:0009310) | 3.22225217 |
| 124 | cellular biogenic amine catabolic process (GO:0042402) | 3.22225217 |
| 125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.21665098 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 3.21477681 |
| 127 | midbrain development (GO:0030901) | 3.21223771 |
| 128 | regulation of receptor binding (GO:1900120) | 3.21021422 |
| 129 | regulation of histone H3-K27 methylation (GO:0061085) | 3.20974925 |
| 130 | regulation of interleukin-13 production (GO:0032656) | 3.20185137 |
| 131 | phospholipid efflux (GO:0033700) | 3.19198478 |
| 132 | carnitine transmembrane transport (GO:1902603) | 3.17965981 |
| 133 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.15373164 |
| 134 | negative regulation of lipase activity (GO:0060192) | 3.15363300 |
| 135 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.14682779 |
| 136 | amyloid precursor protein catabolic process (GO:0042987) | 3.13663028 |
| 137 | lung epithelium development (GO:0060428) | 3.13060296 |
| 138 | amino-acid betaine transport (GO:0015838) | 3.12135153 |
| 139 | carnitine transport (GO:0015879) | 3.12135153 |
| 140 | diterpenoid biosynthetic process (GO:0016102) | 3.10457751 |
| 141 | xenobiotic catabolic process (GO:0042178) | 3.10445301 |
| 142 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.08771156 |
| 143 | water homeostasis (GO:0030104) | 3.08734740 |
| 144 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.07804923 |
| 145 | carnitine shuttle (GO:0006853) | 3.06171075 |
| 146 | regulation of plasminogen activation (GO:0010755) | 3.06145389 |
| 147 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.04526903 |
| 148 | positive regulation of hormone metabolic process (GO:0032352) | 3.02922577 |
| 149 | lung secretory cell differentiation (GO:0061140) | 3.02421334 |
| 150 | cholesterol homeostasis (GO:0042632) | 3.00893259 |
| 151 | pharyngeal system development (GO:0060037) | 2.98859221 |
| 152 | organic acid catabolic process (GO:0016054) | 2.97438422 |
| 153 | carboxylic acid catabolic process (GO:0046395) | 2.97438422 |
| 154 | fibrinolysis (GO:0042730) | 2.97326190 |
| 155 | exogenous drug catabolic process (GO:0042738) | 2.97311882 |
| 156 | glutamate metabolic process (GO:0006536) | 2.97053311 |
| 157 | sterol homeostasis (GO:0055092) | 2.97030060 |
| 158 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.96400550 |
| 159 | response to food (GO:0032094) | 2.93248783 |
| 160 | epithelial cell-cell adhesion (GO:0090136) | 2.92904596 |
| 161 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.89940751 |
| 162 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.89866103 |
| 163 | cellular response to antibiotic (GO:0071236) | 2.88879854 |
| 164 | quaternary ammonium group transport (GO:0015697) | 2.86906875 |
| 165 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.85990943 |
| 166 | regulation of keratinocyte differentiation (GO:0045616) | 2.84500078 |
| 167 | negative regulation of cell size (GO:0045792) | 2.84229580 |
| 168 | cardiac right ventricle morphogenesis (GO:0003215) | 2.84016505 |
| 169 | establishment of skin barrier (GO:0061436) | 2.83260907 |
| 170 | tight junction assembly (GO:0070830) | 2.82471096 |
| 171 | face development (GO:0060324) | 2.82009129 |
| 172 | negative regulation of kidney development (GO:0090185) | 2.78764398 |
| 173 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.78141987 |
| 174 | negative regulation of cell fate commitment (GO:0010454) | 2.76465050 |
| 175 | regulation of interleukin-5 production (GO:0032674) | 2.74647520 |
| 176 | ectodermal placode formation (GO:0060788) | 2.71998573 |
| 177 | endocrine hormone secretion (GO:0060986) | 2.71197615 |
| 178 | establishment of monopolar cell polarity (GO:0061162) | 2.70819014 |
| 179 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.70819014 |
| 180 | epithelial cilium movement (GO:0003351) | 2.68215230 |
| 181 | mesonephros development (GO:0001823) | 2.67623599 |
| 182 | ER overload response (GO:0006983) | 2.67558718 |
| 183 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.67523980 |
| 184 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.67334507 |
| 185 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.67059044 |
| 186 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.66717953 |
| 187 | female genitalia development (GO:0030540) | 2.66126895 |
| 188 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.65397139 |
| 189 | vagina development (GO:0060068) | 2.63664459 |
| 190 | proline metabolic process (GO:0006560) | 2.63552299 |
| 191 | COPII vesicle coating (GO:0048208) | 2.62760323 |
| 192 | norepinephrine metabolic process (GO:0042415) | 2.59693173 |
| 193 | semaphorin-plexin signaling pathway (GO:0071526) | 2.59661095 |
| 194 | trivalent inorganic anion homeostasis (GO:0072506) | 2.57488194 |
| 195 | phosphate ion homeostasis (GO:0055062) | 2.57488194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.69151333 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.12997524 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.33963306 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.06730555 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.69526191 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.84184409 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.64456537 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.45053023 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.12813160 |
| 10 | RACK7_27058665_Chip-Seq_MCF-7_Human | 3.08621733 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.65791777 |
| 12 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.64759982 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.61586576 |
| 14 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.53644872 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.49134063 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.45330064 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.32827679 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.28908953 |
| 19 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.27105695 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.01583789 |
| 21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.99684421 |
| 22 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.88995238 |
| 23 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.86756322 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85303067 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82556303 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.81587712 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74731648 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.73777697 |
| 29 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.71308807 |
| 30 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71022266 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65658998 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.61343049 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59125415 |
| 34 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57317131 |
| 35 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.56486239 |
| 36 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.54482369 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54204397 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.51788295 |
| 39 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.49272531 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48509126 |
| 41 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.48480233 |
| 42 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.44649719 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44386339 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41589717 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40695740 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.40569903 |
| 47 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.36639711 |
| 48 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34485703 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30925956 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30888021 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28284508 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27999945 |
| 53 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.26783208 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26636677 |
| 55 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23527618 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.23515660 |
| 57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22928194 |
| 58 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.21521145 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20894977 |
| 60 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19661455 |
| 61 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19031407 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17875528 |
| 63 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16273811 |
| 64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16012685 |
| 65 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.14971381 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.14414451 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14117014 |
| 68 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11442592 |
| 69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09799704 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09035640 |
| 71 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08618345 |
| 72 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.06161525 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05756012 |
| 74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02650080 |
| 75 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02373793 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01921922 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00654146 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00302863 |
| 79 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97420513 |
| 80 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.96114924 |
| 81 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.95054984 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.94423917 |
| 83 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93280706 |
| 84 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.92400188 |
| 85 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92351497 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91988850 |
| 87 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91697989 |
| 88 | MYC_22102868_ChIP-Seq_BL_Human | 0.91378169 |
| 89 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91169636 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91042440 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.90220276 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89863405 |
| 93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89802803 |
| 94 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89039073 |
| 95 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88898409 |
| 96 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.88107628 |
| 97 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.86309386 |
| 98 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.86125431 |
| 99 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.85485004 |
| 100 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.84705344 |
| 101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84360342 |
| 102 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.83909161 |
| 103 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.83233466 |
| 104 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.83233466 |
| 105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.83233466 |
| 106 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83102525 |
| 107 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.82732596 |
| 108 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.82263805 |
| 109 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82262919 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81552839 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.81549387 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81160939 |
| 113 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80883542 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.80102566 |
| 115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.79980315 |
| 116 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.78590750 |
| 117 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77854221 |
| 118 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77799299 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77733312 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.77733312 |
| 121 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.76945646 |
| 122 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.76571496 |
| 123 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76383196 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76161307 |
| 125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.72802349 |
| 126 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72718448 |
| 127 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.70421573 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70346268 |
| 129 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.69313392 |
| 130 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.68808282 |
| 131 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.68060332 |
| 132 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67748465 |
| 133 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.67360917 |
| 134 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.67074733 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.66124984 |
| 136 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.65645582 |
| 137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65246165 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65246165 |
| 139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.63826236 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.63697142 |
| 141 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.62814173 |
| 142 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.59557660 |
| 143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.59213041 |
| 144 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.58571543 |
| 145 | RXR_22108803_ChIP-Seq_LS180_Human | 0.58286999 |
| 146 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.58129277 |
| 147 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.56936233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21824393 |
| 2 | MP0005360_urolithiasis | 5.14044020 |
| 3 | MP0005365_abnormal_bile_salt | 4.98465277 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.96103087 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.48036757 |
| 6 | MP0002009_preneoplasia | 3.88492181 |
| 7 | MP0001346_abnormal_lacrimal_gland | 3.24908636 |
| 8 | MP0005083_abnormal_biliary_tract | 3.18695098 |
| 9 | MP0000537_abnormal_urethra_morphology | 3.07889628 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.86814035 |
| 11 | MP0000566_synostosis | 2.80806974 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.79606985 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.70325424 |
| 14 | MP0003252_abnormal_bile_duct | 2.56597852 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.54360329 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.47570860 |
| 17 | MP0005076_abnormal_cell_differentiation | 2.47327561 |
| 18 | * MP0010329_abnormal_lipoprotein_level | 2.47262308 |
| 19 | MP0004858_abnormal_nervous_system | 2.30092992 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.24522685 |
| 21 | MP0000383_abnormal_hair_follicle | 2.21836438 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 2.09528412 |
| 23 | MP0002249_abnormal_larynx_morphology | 2.07148108 |
| 24 | MP0003123_paternal_imprinting | 2.06609812 |
| 25 | MP0004233_abnormal_muscle_weight | 1.89769310 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 1.87792243 |
| 27 | MP0008004_abnormal_stomach_pH | 1.87066408 |
| 28 | MP0005332_abnormal_amino_acid | 1.84404506 |
| 29 | MP0005248_abnormal_Harderian_gland | 1.84377590 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.81330645 |
| 31 | MP0002822_catalepsy | 1.78320751 |
| 32 | MP0000462_abnormal_digestive_system | 1.73850238 |
| 33 | MP0003868_abnormal_feces_composition | 1.71966081 |
| 34 | MP0002138_abnormal_hepatobiliary_system | 1.69576337 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.69236162 |
| 36 | MP0004782_abnormal_surfactant_physiolog | 1.61474422 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.58284068 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.56398292 |
| 39 | MP0000609_abnormal_liver_physiology | 1.54831337 |
| 40 | MP0002006_tumorigenesis | 1.52784706 |
| 41 | * MP0000627_abnormal_mammary_gland | 1.51913330 |
| 42 | MP0005310_abnormal_salivary_gland | 1.50725153 |
| 43 | MP0009053_abnormal_anal_canal | 1.49180987 |
| 44 | MP0001919_abnormal_reproductive_system | 1.45297244 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.41354706 |
| 46 | * MP0002118_abnormal_lipid_homeostasis | 1.38096284 |
| 47 | MP0009840_abnormal_foam_cell | 1.35482543 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.34790388 |
| 49 | MP0005501_abnormal_skin_physiology | 1.34351326 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.33576638 |
| 51 | MP0005647_abnormal_sex_gland | 1.31817596 |
| 52 | MP0004381_abnormal_hair_follicle | 1.25077694 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.22128068 |
| 54 | MP0002160_abnormal_reproductive_system | 1.22012971 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 1.21613203 |
| 56 | MP0000613_abnormal_salivary_gland | 1.21006882 |
| 57 | MP0003283_abnormal_digestive_organ | 1.20813086 |
| 58 | MP0000377_abnormal_hair_follicle | 1.19221328 |
| 59 | MP0005187_abnormal_penis_morphology | 1.19001820 |
| 60 | MP0001664_abnormal_digestion | 1.18329274 |
| 61 | MP0001905_abnormal_dopamine_level | 1.17411420 |
| 62 | MP0002132_abnormal_respiratory_system | 1.17186652 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.16054902 |
| 64 | MP0003941_abnormal_skin_development | 1.14541871 |
| 65 | MP0001727_abnormal_embryo_implantation | 1.10183100 |
| 66 | MP0005666_abnormal_adipose_tissue | 1.08982714 |
| 67 | MP0005408_hypopigmentation | 1.08387909 |
| 68 | MP0005381_digestive/alimentary_phenotyp | 1.07799802 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.07597723 |
| 70 | MP0000516_abnormal_urinary_system | 1.06992370 |
| 71 | MP0005367_renal/urinary_system_phenotyp | 1.06992370 |
| 72 | * MP0005220_abnormal_exocrine_pancreas | 1.01344716 |
| 73 | MP0009672_abnormal_birth_weight | 1.00595096 |
| 74 | MP0003315_abnormal_perineum_morphology | 0.99949690 |
| 75 | MP0008995_early_reproductive_senescence | 0.99418536 |
| 76 | * MP0003936_abnormal_reproductive_system | 0.99168731 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.97450111 |
| 78 | MP0005409_darkened_coat_color | 0.95725278 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.94238065 |
| 80 | MP0003186_abnormal_redox_activity | 0.93376013 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.92632832 |
| 82 | MP0003890_abnormal_embryonic-extraembry | 0.92363987 |
| 83 | MP0001764_abnormal_homeostasis | 0.89719296 |
| 84 | MP0001756_abnormal_urination | 0.89133317 |
| 85 | MP0001663_abnormal_digestive_system | 0.87759663 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.87494968 |
| 87 | MP0000427_abnormal_hair_cycle | 0.85701636 |
| 88 | MP0006276_abnormal_autonomic_nervous | 0.85076775 |
| 89 | MP0002282_abnormal_trachea_morphology | 0.84868952 |
| 90 | MP0003943_abnormal_hepatobiliary_system | 0.84855381 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.83860378 |
| 92 | MP0003937_abnormal_limbs/digits/tail_de | 0.83413691 |
| 93 | MP0003191_abnormal_cellular_cholesterol | 0.82871171 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.81596502 |
| 95 | MP0002736_abnormal_nociception_after | 0.81339093 |
| 96 | MP0001299_abnormal_eye_distance/ | 0.81318107 |
| 97 | MP0004133_heterotaxia | 0.80488996 |
| 98 | MP0002108_abnormal_muscle_morphology | 0.80432109 |
| 99 | MP0009703_decreased_birth_body | 0.80324205 |
| 100 | MP0002116_abnormal_craniofacial_bone | 0.80029563 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.80025438 |
| 102 | MP0009764_decreased_sensitivity_to | 0.79120661 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.79109828 |
| 104 | MP0002796_impaired_skin_barrier | 0.78030616 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.76862081 |
| 106 | MP0001340_abnormal_eyelid_morphology | 0.76090462 |
| 107 | MP0003115_abnormal_respiratory_system | 0.75632687 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.74661650 |
| 109 | MP0003011_delayed_dark_adaptation | 0.74594093 |
| 110 | MP0002111_abnormal_tail_morphology | 0.74549288 |
| 111 | MP0001873_stomach_inflammation | 0.74432756 |
| 112 | MP0003718_maternal_effect | 0.74090818 |
| 113 | MP0000534_abnormal_ureter_morphology | 0.74045114 |
| 114 | MP0005451_abnormal_body_composition | 0.73612681 |
| 115 | MP0002254_reproductive_system_inflammat | 0.73465543 |
| 116 | MP0002735_abnormal_chemical_nociception | 0.71827999 |
| 117 | MP0003942_abnormal_urinary_system | 0.71604213 |
| 118 | MP0002088_abnormal_embryonic_growth/wei | 0.71346724 |
| 119 | MP0003959_abnormal_lean_body | 0.71136924 |
| 120 | MP0003938_abnormal_ear_development | 0.71077416 |
| 121 | MP0003119_abnormal_digestive_system | 0.70320379 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.70292463 |
| 123 | MP0003705_abnormal_hypodermis_morpholog | 0.69169911 |
| 124 | MP0002234_abnormal_pharynx_morphology | 0.68735946 |
| 125 | MP0004883_abnormal_blood_vessel | 0.68659416 |
| 126 | MP0002896_abnormal_bone_mineralization | 0.66578111 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.66132756 |
| 128 | MP0003984_embryonic_growth_retardation | 0.65235302 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.65077431 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.64874743 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.64367297 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.64172327 |
| 133 | MP0005448_abnormal_energy_balance | 0.63552373 |
| 134 | MP0002092_abnormal_eye_morphology | 0.61244490 |
| 135 | MP0000598_abnormal_liver_morphology | 0.61146186 |
| 136 | MP0003638_abnormal_response/metabolism_ | 0.59884308 |
| 137 | MP0001529_abnormal_vocalization | 0.59510661 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.58841378 |
| 139 | MP0002697_abnormal_eye_size | 0.58405821 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.57013912 |
| 141 | MP0003880_abnormal_central_pattern | 0.56734008 |
| 142 | MP0000470_abnormal_stomach_morphology | 0.55606068 |
| 143 | MP0000579_abnormal_nail_morphology | 0.55271261 |
| 144 | MP0005197_abnormal_uvea_morphology | 0.54937276 |
| 145 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.54178029 |
| 146 | MP0008872_abnormal_physiological_respon | 0.52726946 |
| 147 | MP0000477_abnormal_intestine_morphology | 0.52133068 |
| 148 | MP0000467_abnormal_esophagus_morphology | 0.50870099 |
| 149 | * MP0009642_abnormal_blood_homeostasis | 0.49996673 |
| 150 | MP0001881_abnormal_mammary_gland | 0.47041444 |
| 151 | MP0000647_abnormal_sebaceous_gland | 0.46947862 |
| 152 | MP0005395_other_phenotype | 0.45490004 |
| 153 | MP0002136_abnormal_kidney_physiology | 0.44982321 |
| 154 | * MP0001944_abnormal_pancreas_morphology | 0.44914750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.11227061 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.81659495 |
| 3 | Concave nail (HP:0001598) | 5.67135925 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.66019862 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.47379804 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.32427621 |
| 7 | Septate vagina (HP:0001153) | 5.31267600 |
| 8 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.17225614 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.12283276 |
| 10 | Hyperglycinemia (HP:0002154) | 5.12051640 |
| 11 | Sparse lateral eyebrow (HP:0005338) | 4.99342819 |
| 12 | Hyperglycinuria (HP:0003108) | 4.80398331 |
| 13 | Flat acetabular roof (HP:0003180) | 4.50581392 |
| 14 | Xanthomatosis (HP:0000991) | 4.43904921 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 4.34355580 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.34355580 |
| 17 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.26432712 |
| 18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.26432712 |
| 19 | Fat malabsorption (HP:0002630) | 4.23759550 |
| 20 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.23516233 |
| 21 | Complement deficiency (HP:0004431) | 4.21192874 |
| 22 | Chronic bronchitis (HP:0004469) | 4.07633048 |
| 23 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.06743443 |
| 24 | Absent/shortened dynein arms (HP:0200106) | 4.06743443 |
| 25 | Testicular atrophy (HP:0000029) | 4.06425282 |
| 26 | Rhinitis (HP:0012384) | 3.99251842 |
| 27 | Abnormal ciliary motility (HP:0012262) | 3.96125388 |
| 28 | Gout (HP:0001997) | 3.85582029 |
| 29 | Hypolipoproteinemia (HP:0010981) | 3.81645564 |
| 30 | Anterior segment dysgenesis (HP:0007700) | 3.68500250 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.59549817 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.58072354 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.56764820 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.51645453 |
| 35 | Ileus (HP:0002595) | 3.38958927 |
| 36 | Lip pit (HP:0100267) | 3.34978038 |
| 37 | Steatorrhea (HP:0002570) | 3.30884618 |
| 38 | Hyperammonemia (HP:0001987) | 3.29542257 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 3.29374258 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.23256165 |
| 41 | Germ cell neoplasia (HP:0100728) | 3.22092561 |
| 42 | Asymmetry of the thorax (HP:0001555) | 3.20342316 |
| 43 | Broad face (HP:0000283) | 3.14540311 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.12751097 |
| 45 | Ketosis (HP:0001946) | 3.08294621 |
| 46 | Joint hemorrhage (HP:0005261) | 3.04402624 |
| 47 | Testicular neoplasm (HP:0010788) | 3.04227050 |
| 48 | Right ventricular cardiomyopathy (HP:0011663) | 2.98532842 |
| 49 | Epidermoid cyst (HP:0200040) | 2.97455714 |
| 50 | Malnutrition (HP:0004395) | 2.94766929 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 2.90311270 |
| 52 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.89679224 |
| 53 | Abnormality of complement system (HP:0005339) | 2.89046395 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.79798315 |
| 55 | Bronchiectasis (HP:0002110) | 2.72203871 |
| 56 | Amelogenesis imperfecta (HP:0000705) | 2.72184163 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.64184996 |
| 58 | Glomerulonephritis (HP:0000099) | 2.63550794 |
| 59 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.62520062 |
| 60 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.62503592 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.61444247 |
| 62 | Limb dystonia (HP:0002451) | 2.57531194 |
| 63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.54365610 |
| 64 | Anal stenosis (HP:0002025) | 2.52557835 |
| 65 | Abnormality of carpal bone ossification (HP:0006257) | 2.50609676 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50111916 |
| 67 | Macroorchidism (HP:0000053) | 2.49747343 |
| 68 | J-shaped sella turcica (HP:0002680) | 2.49260751 |
| 69 | Esophageal varix (HP:0002040) | 2.47814187 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46672511 |
| 71 | Spontaneous abortion (HP:0005268) | 2.44237462 |
| 72 | Spinal cord compression (HP:0002176) | 2.44166187 |
| 73 | Absent frontal sinuses (HP:0002688) | 2.43145792 |
| 74 | Polar cataract (HP:0010696) | 2.41491254 |
| 75 | Short nail (HP:0001799) | 2.40766263 |
| 76 | Abnormal cartilage morphology (HP:0002763) | 2.40262067 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 2.36829209 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.34726839 |
| 79 | Hypoparathyroidism (HP:0000829) | 2.33148791 |
| 80 | Infertility (HP:0000789) | 2.31865655 |
| 81 | Hyperactive renin-angiotensin system (HP:0000841) | 2.31856715 |
| 82 | Curly hair (HP:0002212) | 2.31263396 |
| 83 | Vascular calcification (HP:0004934) | 2.31146970 |
| 84 | Abnormality of the axillary hair (HP:0100134) | 2.29027402 |
| 85 | Abnormality of secondary sexual hair (HP:0009888) | 2.29027402 |
| 86 | Potter facies (HP:0002009) | 2.27535995 |
| 87 | Facial shape deformation (HP:0011334) | 2.27535995 |
| 88 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.27112922 |
| 89 | Lethargy (HP:0001254) | 2.26786409 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25540154 |
| 91 | Congenital glaucoma (HP:0001087) | 2.25289365 |
| 92 | Bifid scrotum (HP:0000048) | 2.24170916 |
| 93 | Depressed nasal tip (HP:0000437) | 2.23410095 |
| 94 | Onycholysis (HP:0001806) | 2.22053863 |
| 95 | Hyperacusis (HP:0010780) | 2.22036596 |
| 96 | Thin bony cortex (HP:0002753) | 2.20326156 |
| 97 | Flattened epiphyses (HP:0003071) | 2.19332425 |
| 98 | Breast carcinoma (HP:0003002) | 2.16436760 |
| 99 | Abnormality of the dental root (HP:0006486) | 2.14653636 |
| 100 | Taurodontia (HP:0000679) | 2.14653636 |
| 101 | Abnormality of permanent molar morphology (HP:0011071) | 2.14653636 |
| 102 | Abnormal hand bone ossification (HP:0010660) | 2.12704740 |
| 103 | Nasal polyposis (HP:0100582) | 2.12412235 |
| 104 | Hyperuricemia (HP:0002149) | 2.11835656 |
| 105 | Increased purine levels (HP:0004368) | 2.11835656 |
| 106 | Abnormality of the nasal septum (HP:0000419) | 2.10121496 |
| 107 | Ketoacidosis (HP:0001993) | 2.10074447 |
| 108 | Abnormal ossification of hand bones (HP:0005921) | 2.09445620 |
| 109 | Spastic diplegia (HP:0001264) | 2.09299734 |
| 110 | Abnormality of the 1st metacarpal (HP:0010009) | 2.04238309 |
| 111 | Aplasia of the musculature (HP:0100854) | 2.03871025 |
| 112 | Metabolic acidosis (HP:0001942) | 2.03794136 |
| 113 | Abnormal pancreas size (HP:0012094) | 2.03077228 |
| 114 | Abnormal tarsal ossification (HP:0008369) | 2.00024412 |
| 115 | Short 1st metacarpal (HP:0010034) | 1.99908747 |
| 116 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.99908747 |
| 117 | Hyperbilirubinemia (HP:0002904) | 1.97900515 |
| 118 | Irritability (HP:0000737) | 1.97287885 |
| 119 | Bronchomalacia (HP:0002780) | 1.96566759 |
| 120 | Cardiovascular calcification (HP:0011915) | 1.96195428 |
| 121 | Gonadotropin excess (HP:0000837) | 1.95383824 |
| 122 | Cone-rod dystrophy (HP:0000548) | 1.95231135 |
| 123 | Abnormality of the frontal sinuses (HP:0002687) | 1.93863775 |
| 124 | Abnormality of methionine metabolism (HP:0010901) | 1.93425342 |
| 125 | Congenital, generalized hypertrichosis (HP:0004540) | 1.91885497 |
| 126 | Microglossia (HP:0000171) | 1.91639504 |
| 127 | Advanced eruption of teeth (HP:0006288) | 1.90382684 |
| 128 | Partial duplication of thumb phalanx (HP:0009944) | 1.90288790 |
| 129 | Growth hormone excess (HP:0000845) | 1.90281137 |
| 130 | Abnormality of the fingertips (HP:0001211) | 1.90228624 |
| 131 | Abnormality of the gastric mucosa (HP:0004295) | 1.90027380 |
| 132 | Calf muscle hypertrophy (HP:0008981) | 1.88698635 |
| 133 | Morphological abnormality of the inner ear (HP:0011390) | 1.88303427 |
| 134 | Pili torti (HP:0003777) | 1.87636273 |
| 135 | Obstructive sleep apnea (HP:0002870) | 1.87610269 |
| 136 | Abnormality of molar (HP:0011077) | 1.87436903 |
| 137 | Abnormality of molar morphology (HP:0011070) | 1.87436903 |
| 138 | Abnormality of the parathyroid morphology (HP:0011766) | 1.87267156 |
| 139 | Microretrognathia (HP:0000308) | 1.87013850 |
| 140 | Hyperparathyroidism (HP:0000843) | 1.86925068 |
| 141 | Recurrent otitis media (HP:0000403) | 1.86883411 |
| 142 | Acanthocytosis (HP:0001927) | 1.86721084 |
| 143 | Hypoglycemic coma (HP:0001325) | 1.85829122 |
| 144 | Abnormal foot bone ossification (HP:0010675) | 1.85070809 |
| 145 | Abnormality of proline metabolism (HP:0010907) | 1.84589812 |
| 146 | Hydroxyprolinuria (HP:0003080) | 1.84589812 |
| 147 | Micronodular cirrhosis (HP:0001413) | 1.83200825 |
| 148 | Abnormality of the dental pulp (HP:0006479) | 1.82987620 |
| 149 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.82757153 |
| 150 | 11 pairs of ribs (HP:0000878) | 1.82563972 |
| 151 | Nephritis (HP:0000123) | 1.81834736 |
| 152 | Broad nasal tip (HP:0000455) | 1.81533145 |
| 153 | Prostate neoplasm (HP:0100787) | 1.81332214 |
| 154 | Cervical subluxation (HP:0003308) | 1.80482054 |
| 155 | Self-mutilation (HP:0000742) | 1.79552008 |
| 156 | Azoospermia (HP:0000027) | 1.79374463 |
| 157 | Termporal pattern (HP:0011008) | 1.77104364 |
| 158 | Insidious onset (HP:0003587) | 1.77104364 |
| 159 | Glomerulosclerosis (HP:0000096) | 1.77076177 |
| 160 | Hypoplasia of the uterus (HP:0000013) | 1.76063508 |
| 161 | Hyperkalemia (HP:0002153) | 1.76036551 |
| 162 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.76009465 |
| 163 | Pancreatitis (HP:0001733) | 1.75956902 |
| 164 | Brushfield spots (HP:0001088) | 1.75683501 |
| 165 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.74612006 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.74491611 |
| 167 | Skin nodule (HP:0200036) | 1.74443752 |
| 168 | Exostoses (HP:0100777) | 1.74219297 |
| 169 | Short femoral neck (HP:0100864) | 1.74190766 |
| 170 | Atelectasis (HP:0100750) | 1.73319134 |
| 171 | Long toe (HP:0010511) | 1.72882628 |
| 172 | Menorrhagia (HP:0000132) | 1.72635164 |
| 173 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.72626993 |
| 174 | Short phalanx of the thumb (HP:0009660) | 1.72449219 |
| 175 | Neonatal hypoglycemia (HP:0001998) | 1.69619004 |
| 176 | Cerebral edema (HP:0002181) | 1.68579253 |
| 177 | Glycosuria (HP:0003076) | 1.68218845 |
| 178 | Abnormality of urine glucose concentration (HP:0011016) | 1.68218845 |
| 179 | Abdominal distention (HP:0003270) | 1.67960455 |
| 180 | Delayed CNS myelination (HP:0002188) | 1.67128690 |
| 181 | Biliary tract neoplasm (HP:0100574) | 1.66843908 |
| 182 | Abnormality of the anterior chamber (HP:0000593) | 1.66683607 |
| 183 | Hyperglycemia (HP:0003074) | 1.66682690 |
| 184 | Hypochromic microcytic anemia (HP:0004840) | 1.64701445 |
| 185 | Back pain (HP:0003418) | 1.64682706 |
| 186 | Respiratory distress (HP:0002098) | 1.64026134 |
| 187 | Abnormality of chloride homeostasis (HP:0011422) | 1.63619073 |
| 188 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.63474714 |
| 189 | Late onset (HP:0003584) | 1.62548624 |
| 190 | Abnormal biliary tract morphology (HP:0012440) | 1.62098239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 3.92735517 |
| 2 | EPHA2 | 3.63972959 |
| 3 | EPHB2 | 3.53038266 |
| 4 | ERN1 | 3.26427407 |
| 5 | PKN2 | 3.17054563 |
| 6 | AKT3 | 3.16468942 |
| 7 | BCKDK | 3.03725179 |
| 8 | SIK1 | 2.97669439 |
| 9 | TAOK1 | 2.89240958 |
| 10 | FRK | 2.79326114 |
| 11 | MST1R | 2.78911015 |
| 12 | TAOK3 | 2.62398885 |
| 13 | MST4 | 2.58396135 |
| 14 | SMG1 | 2.57107733 |
| 15 | TNK2 | 2.54971124 |
| 16 | MAPKAPK3 | 2.40728386 |
| 17 | STK39 | 2.38764391 |
| 18 | KSR1 | 2.35805258 |
| 19 | PRKD3 | 2.32800507 |
| 20 | MAPK15 | 2.32448721 |
| 21 | SCYL2 | 2.26220214 |
| 22 | MAP2K2 | 2.12287821 |
| 23 | ERBB4 | 2.12283198 |
| 24 | LMTK2 | 2.10395711 |
| 25 | ERBB2 | 2.05080697 |
| 26 | NUAK1 | 1.85380969 |
| 27 | BCR | 1.76765800 |
| 28 | CSNK1G3 | 1.70916470 |
| 29 | MUSK | 1.70250494 |
| 30 | SIK3 | 1.64990042 |
| 31 | DYRK1B | 1.62578509 |
| 32 | TESK1 | 1.60615069 |
| 33 | CSNK1G1 | 1.60116529 |
| 34 | DYRK3 | 1.59073033 |
| 35 | CDK12 | 1.56708535 |
| 36 | IRAK3 | 1.55535006 |
| 37 | PTK6 | 1.45921967 |
| 38 | MAP3K12 | 1.45056734 |
| 39 | PIM2 | 1.43714978 |
| 40 | STK38L | 1.38603965 |
| 41 | FGFR4 | 1.38036714 |
| 42 | STK3 | 1.37986007 |
| 43 | CSNK1G2 | 1.33187936 |
| 44 | CDK7 | 1.31480257 |
| 45 | PRKD2 | 1.25497518 |
| 46 | MARK1 | 1.24727104 |
| 47 | INSRR | 1.23006633 |
| 48 | EIF2AK1 | 1.18587844 |
| 49 | NEK6 | 1.17961880 |
| 50 | ERBB3 | 1.16832508 |
| 51 | DAPK2 | 1.14894105 |
| 52 | FGFR2 | 1.12394436 |
| 53 | MAP3K2 | 1.11604997 |
| 54 | FER | 1.09987878 |
| 55 | DYRK2 | 1.09037060 |
| 56 | OXSR1 | 1.05665487 |
| 57 | PTK2 | 1.05523978 |
| 58 | MYLK | 0.99945625 |
| 59 | LATS2 | 0.98195188 |
| 60 | MARK2 | 0.91809629 |
| 61 | TRIB3 | 0.90700026 |
| 62 | TESK2 | 0.88949498 |
| 63 | STK16 | 0.88133630 |
| 64 | RPS6KB2 | 0.87398985 |
| 65 | NME1 | 0.85448405 |
| 66 | BMPR1B | 0.84452032 |
| 67 | TGFBR1 | 0.84116078 |
| 68 | RPS6KA2 | 0.82990817 |
| 69 | ILK | 0.80751373 |
| 70 | MAP3K3 | 0.80362216 |
| 71 | MAP2K6 | 0.80238947 |
| 72 | YES1 | 0.80060934 |
| 73 | MAP2K1 | 0.78955321 |
| 74 | PAK4 | 0.74982463 |
| 75 | CSNK1A1L | 0.74879070 |
| 76 | IRAK2 | 0.74703125 |
| 77 | MAP2K4 | 0.73150582 |
| 78 | GRK6 | 0.72606375 |
| 79 | MET | 0.72566349 |
| 80 | NME2 | 0.69797576 |
| 81 | PAK3 | 0.66804946 |
| 82 | HIPK2 | 0.66205531 |
| 83 | TAF1 | 0.65557717 |
| 84 | MAPK13 | 0.65388100 |
| 85 | PIK3CG | 0.64103554 |
| 86 | PRKAA1 | 0.63770398 |
| 87 | PRKCI | 0.61107797 |
| 88 | PNCK | 0.60895111 |
| 89 | LRRK2 | 0.59576354 |
| 90 | EEF2K | 0.59210348 |
| 91 | AKT2 | 0.58829776 |
| 92 | RET | 0.58445681 |
| 93 | SRPK1 | 0.57802701 |
| 94 | RIPK1 | 0.57457072 |
| 95 | MELK | 0.57261517 |
| 96 | GSK3A | 0.56377748 |
| 97 | PRKCZ | 0.55318676 |
| 98 | RPS6KB1 | 0.54960220 |
| 99 | UHMK1 | 0.54447420 |
| 100 | VRK2 | 0.54104303 |
| 101 | PAK2 | 0.53937704 |
| 102 | PDPK1 | 0.53651554 |
| 103 | CSNK1E | 0.51491086 |
| 104 | DYRK1A | 0.50234631 |
| 105 | MAP3K9 | 0.48941683 |
| 106 | CDK6 | 0.47903669 |
| 107 | CAMKK1 | 0.46961207 |
| 108 | MAPK11 | 0.45400357 |
| 109 | RPS6KA1 | 0.44777967 |
| 110 | MAPK4 | 0.44586583 |
| 111 | ICK | 0.44456093 |
| 112 | RPS6KC1 | 0.44074342 |
| 113 | RPS6KL1 | 0.44074342 |
| 114 | BUB1 | 0.42281083 |
| 115 | CAMK1G | 0.40601380 |
| 116 | BRSK2 | 0.40372317 |
| 117 | SIK2 | 0.38492716 |
| 118 | PRKD1 | 0.38035042 |
| 119 | CAMK2B | 0.36881835 |
| 120 | STK38 | 0.36730393 |
| 121 | TSSK6 | 0.36464428 |
| 122 | RPS6KA6 | 0.35662489 |
| 123 | CHUK | 0.34276061 |
| 124 | CAMK2G | 0.33878581 |
| 125 | RPS6KA4 | 0.32379365 |
| 126 | AURKB | 0.31987965 |
| 127 | SGK3 | 0.31247815 |
| 128 | GRK1 | 0.30953190 |
| 129 | MAP3K11 | 0.30899560 |
| 130 | PRKAA2 | 0.30862252 |
| 131 | MINK1 | 0.28849009 |
| 132 | AURKA | 0.28505719 |
| 133 | JAK2 | 0.28235462 |
| 134 | MTOR | 0.27923437 |
| 135 | SGK223 | 0.27678369 |
| 136 | SGK494 | 0.27678369 |
| 137 | DMPK | 0.27451131 |
| 138 | TYK2 | 0.27283571 |
| 139 | MAPK8 | 0.26268303 |
| 140 | ADRBK1 | 0.24223568 |
| 141 | ROCK1 | 0.24210544 |
| 142 | MAPKAPK2 | 0.24014622 |
| 143 | SGK2 | 0.23873349 |
| 144 | WEE1 | 0.23373768 |
| 145 | BRSK1 | 0.22814791 |
| 146 | CSNK1A1 | 0.22292610 |
| 147 | PRKACG | 0.20458722 |
| 148 | MAPK14 | 0.20186272 |
| 149 | WNK4 | 0.19667997 |
| 150 | CAMK1D | 0.19304799 |
| 151 | TGFBR2 | 0.18977039 |
| 152 | GRK5 | 0.18798888 |
| 153 | PIK3CA | 0.18747239 |
| 154 | GSK3B | 0.18213344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.84122843 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29138723 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.04598325 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.79988537 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79626682 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.76028984 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.61333450 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.59025615 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46485612 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41363406 |
| 11 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.35704719 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35306851 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26300470 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.24677664 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.24346036 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.22274115 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18027334 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16288314 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08283151 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.08141503 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 2.01129325 |
| 22 | Prostate cancer_Homo sapiens_hsa05215 | 1.95376311 |
| 23 | Thyroid cancer_Homo sapiens_hsa05216 | 1.83697008 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.81653422 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.80917853 |
| 26 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.80380364 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79199271 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77249070 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75413079 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72946558 |
| 31 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71747812 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.69527290 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69074640 |
| 34 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.68989341 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.64345420 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60756002 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56892713 |
| 38 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.51256957 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50249067 |
| 40 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.49321759 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47538325 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.46969618 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45001508 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.38824287 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.37858966 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36879823 |
| 47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.34294543 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.32643640 |
| 49 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.32580294 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31323199 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29984999 |
| 52 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.29779993 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.22786657 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21405877 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21313948 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18928551 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12262216 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11698340 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.11182219 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.09781395 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08569529 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.04503908 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02125021 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98542507 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.98348600 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97671044 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.94350716 |
| 68 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93843628 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92975138 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92062959 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91349584 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.89607902 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89105062 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88278490 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87934112 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84876249 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83485689 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81274899 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.79828327 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79097337 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78235261 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78038937 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74951584 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67765461 |
| 85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65215267 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63864943 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62942391 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60325257 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55249065 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52462486 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52238651 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51169451 |
| 93 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50095683 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48622042 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48167160 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.48153980 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.47753555 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47251370 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46605174 |
| 100 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45526016 |
| 101 | Melanogenesis_Homo sapiens_hsa04916 | 0.45452319 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44756465 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.43228214 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.42939167 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41564688 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41267025 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.40998963 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40050610 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39612559 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.39165476 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38956826 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36524375 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36124425 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36066271 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35624392 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35594977 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33158965 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.32379301 |
| 119 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.28337633 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26665871 |
| 121 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25313778 |
| 122 | Prion diseases_Homo sapiens_hsa05020 | 0.24526834 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.23821839 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19906818 |
| 125 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.19753589 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.16993007 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16140852 |
| 128 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14303988 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.11786463 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.11725231 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11232144 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10939412 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10619462 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10112339 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10035633 |
| 136 | Protein export_Homo sapiens_hsa03060 | 0.09616622 |
| 137 | Adherens junction_Homo sapiens_hsa04520 | 0.09542026 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.07786563 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.04626334 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.03548417 |
| 141 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.03394335 |
| 142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.03319530 |
| 143 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.02810310 |

